Message from Gloria Antonio, Executive Manager, Marketing & Business Delivery
Greetings since my last update. As the end of the year fast approaches, I wanted to provide an update on current activities relating to shared goals.
We have commenced a collaboration with the National Centre for Immunisation Research and Surveillance (NCIRS) for the PHN Immunisation support program, and last week saw some of you at the first successful workshop in Adelaide. We look forward to working with many of you in this immunisation space over the coming months and seeing some of you at the upcoming workshops in Brisbane and Sydney.
I’ve also included an update on our most recent therapeutic program which focuses on osteoarthritis; the real-time prescription monitoring training currently underway in Victoria; and reframing codeine, our awareness campaign for health professionals and consumers around the up-scheduling of codeine. Finally, I am pleased to announce next year’s National Medicines Symposium, and invite you to submit abstracts. It would be wonderful to showcase the great variety of work from PHNs across the country at this unique cross-disciplinary event.
In this issue:
- Primary Health Network Immunisation Support Program
- Reframing codeine – supporting changes to supply
- Partnership spotlight: Real-time prescription monitoring prescriber and pharmacist training
- Osteoarthritis: practical tools for diagnosis and management
- National Medicines Symposium 2018 - Population to Personal Health Care
As always, if you have any questions or feedback I look forward to hearing from you.
Marketing & Business Delivery
Primary Health Network Immunisation Support Program
We have commenced work on the Primary Health Network immunisation support service, in partnership with the National Centre for Immunisation Research and Surveillance (NCIRS).
The service aims to provide support to PHNs in delivering immunisation programs to your patients and communities, consistent with the Australian Immunisation Handbook and National Immunisation Program (NIP). The two-year program is funded by Commonwealth Department of Health and will deliver a national and coordinated approach.
In partnership with NCIRS we are running 1-day workshops using the principles of human-centred design to explore the challenges and needs of and brainstorm possible solutions.
The first workshop was held last week in Adelaide. It was a successful day with excellent collaboration and ideas and we’d like to thank all the participants for their time and contribution in the day.
17 October 2017 – Brisbane QLD
19 October 2017 – Sydney NSW
Reframing codeine – supporting changes to supply
From 1 February 2018, medicines that contain low-dose codeine will no longer be available without prescription in pharmacies.
The medicines affected include codeine-containing combination analgesics, available under brand names such as Panadeine, Nurofen Plus and Mersyndol, and pharmacy generic pain relief products, and codeine-containing cough, cold and flu products, available under brand ranges such as Codral, Demazin and pharmacy generic cough, cold and flu medicines.
We are working with industry and consumer groups to facilitate a smooth transition of this change and have created resources to assist discussions.
PARTNERSHIP SPOTLIGHT - Real-time prescription monitoring prescriber and pharmacist training
Background work for Real-Time Prescription Monitoring Prescriber and Pharmacist Training is currently underway. NPS MedicineWise, and consortium partner the Victorian PHN Alliance, with Western Victoria Primary Health Network as lead agency, are working with the Department of Health and Human Services (Victoria) to design, develop and deliver the training.
This significant training package is a key component of a range of workforce initiatives that will enable health practitioners to safely respond to patients who may be misusing prescription medicines or receiving supplies of high-risk medicines beyond therapeutic need.
The consortium has a successful track record supporting health reform implementation and training delivery. Victorian PHN Alliance brings in-depth technical expertise, detailed local knowledge and substantial reach to prescribers and pharmacists across Victoria. NPS MedicineWise brings over 20 years’ experience delivering high quality, evidence-based education programs to health professionals nationally.
We will provide updates on the Real-Time Prescription Monitoring Prescriber and Pharmacist training as they become available.
Osteoarthritis: practical tools for diagnosis and management
We have just launched our next therapeutic program which aims to support you to improve quality of life for your patients with osteoarthritis. Osteoarthritis of the knee or hip may be a common condition for many of your patients. But pain and loss of function are not inevitable. Early exercise and weight management can help with pain and mobility – and can often prevent or slow disease progression before irreversible joint damage occurs.
This program is CPD and PIP accredited, and provides the latest practical advice and resources to help improve quality of life for your patients with osteoarthritis.
Population to Personal Health Care: National Medicines Symposium 2018
We are pleased to announce the tenth National Medicines Symposium (NMS) will be held from 30 May to 1 June 2018 in Canberra. The theme for next year’s event is 'Population to personal healthcare: the future is now'.
We encourage PHNs to submit abstracts and attend this unique cross-disciplinary event that brings together some of the most influential organisations, individuals and decision makers in the health sector to debate and discuss quality use of medicines, diagnostics and health data challenges and opportunities.
At this event we will explore what changes to health technology, personalised medicine and disruptive innovation is transforming health care as we know and experience it means for health systems, health policies and clinical practice in real terms, and how it influences decision making at all levels.
NMS is the pre-eminent quality use of medicines, diagnostics and health data symposium in Australia. Held every two years, the program is designed to provide the latest and most thought-provoking content in the medicines and health environment, delivered by international and nationally acclaimed experts.